Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin.
about
Pharmaceutical-grade albumin: impaired drug-binding capacity in vitroTryptophan metabolism, disposition and utilization in pregnancyStereo-selectivity of human serum albumin to enantiomeric and isoelectronic pollutants dissected by spectroscopy, calorimetry and bioinformaticsMobile phase modifier effects in multimodal cation exchange chromatography.Ligand binding strategies of human serum albumin: how can the cargo be utilized?Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.Increase of octanoate concentrations during extracorporeal albumin dialysis treatments.The role of caprylate ligand ion on the stabilization of human serum albumin.Interactive association between RhoA transcriptional signaling inhibitor, CCG1423 and human serum albumin: Biophysical and in silico studies.Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin.Determination of protein-ligand binding affinity by NMR: observations from serum albumin model systems.Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES.Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.Reversible binding of ethacrynic acid to human serum albumin: difference circular dichroism study.Polymeric Membranes for Chiral Separation of Pharmaceuticals and ChemicalsRecognition of Amino Acids by Membrane Potential of Immobilized Serum Albumin MembranesAnalysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure
P2860
Q24798284-8099B47B-DE36-44AD-8FF8-FA66F6F55FC6Q26783616-1C890542-133D-4351-A03F-68E386AE98E0Q28477752-BEF7BF20-1051-4403-879F-ACFD0126F59AQ34013052-7EBF2091-5F4D-477A-8B24-5B4E74D49FB9Q37423260-BCEB8445-DC14-4BC1-91AE-36473296D531Q38461901-683236EA-5AF4-41E0-8EFE-E317487E4D53Q38471039-58F981C4-E9E3-485D-9CD4-5272588BDAE4Q38555147-29548CF9-AA5A-4429-9C32-88C24BD4A2BCQ38658014-FA2EDFB7-9555-4FA4-AD59-34A742926ABEQ44697239-547B9612-7594-4635-A210-A08A23DD9BBBQ46426420-FAF4BE70-113A-408F-9385-E165D1586C98Q46758124-E00E4CCA-D67C-443A-AE30-F6734603A0C4Q47549302-66307F00-565E-4843-A09A-7A447F1B2090Q51479381-DC95ACAB-D083-4263-8C70-796F84D1AF0AQ57083467-CF36B2D6-D791-43E5-A1ED-FE9689A33FFFQ57083531-CE395735-C908-437A-A289-066CA1E1843BQ58581011-BA2BD8A6-4EAB-44D0-8FAE-65F5F51C1088
P2860
Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Octanoate binding to the indol ...... region of human serum albumin.
@en
type
label
Octanoate binding to the indol ...... region of human serum albumin.
@en
prefLabel
Octanoate binding to the indol ...... region of human serum albumin.
@en
P2860
P356
P1433
P1476
Octanoate binding to the indol ...... region of human serum albumin.
@en
P2093
U Kragh-Hansen
P2860
P304
P356
10.1042/BJ2730641
P407
P478
273 ( Pt 3)
P577
1991-02-01T00:00:00Z